dr. hardesty on bevacizumab/parp inhibitor combination in ovarian cancer
Published 5 years ago • 264 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
5:55
maintenance therapy: parp inhibitor or bevacizumab
-
3:42
parp maintenance bevacizumab in ovarian cancer
-
4:54
bevacizumab in recurrent ovarian cancer
-
0:51
dr. hays on potential for parp inhibitor combinations in ovarian cancer
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:41
dr. mirza on niraparib plus bevacizumab combo in ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
2:27
the paola-1 study: olaparib and bevacizumab for ovarian cancer
-
1:36
dr. tew evaluates bevacizumab treatment in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:05
dr. essel discusses long-term bevacizumab in ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
5:32
parp inhibitor olaparib added to bevacizumab benefits women with ovarian cancer with and without...
-
7:32
bevacizumab for recurrent ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer